|
Patient Case - Anti-NMDA Receptor Encephalitis |
03/07/2022 - 2:00pm to 3:00pm EST |
|
Patient Case - Acute Disseminated Encephalomyelitis |
12/12/2022 - 2:00pm to 3:00pm EST |
|
Journal Club - Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2 Trial) |
10/10/2022 - 2:00pm to 3:00pm EDT |
|
Journal Club - Time to Hit "Snooze" on insomnia use disorder with daridorexant |
09/26/2022 - 2:00pm to 3:00pm EDT |
|
Journal Club - The new key to management of VOC? |
02/07/2022 - 2:00pm to 3:00pm EST |
|
Journal Club - Pseudomonas aeruginosa 8 vs 15 days for VAP in adults |
08/08/2022 - 2:00pm to 3:00pm EDT |
|
Journal Club - On the Straight and Narrow? Overuse of Pseudomonas Coverage for CA-IAI |
08/22/2022 - 2:00pm to 3:00pm EDT |
|
Journal Club - Is VICTORIA Victorious? - Safety and Efficacy of Vericiguat in Patients with HFrEF |
08/29/2022 - 2:00pm to 3:00pm EDT |
|
Journal Club - Intravenous Milrinone for Cerebral Vasospasm in Subarachnoid Hemorrhage |
09/12/2022 - 2:00pm to 3:00pm EDT |
|
Journal Club - Effects of Early Empagliflozin Initiation on Diuresis and Kidney Function in Patients With Acute Decompensated Heart Failure (EMPAG-HF) |
10/03/2022 - 2:00pm to 3:00pm EDT |
Facebook
Twitter
LinkedIn
Forward